Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study.

@article{Panichi2010ImpactOC,
  title={Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study.},
  author={Vincenzo Panichi and Roberto Bigazzi and Sabrina Paoletti and Emanuela Mantuano and Sara Beati and Valentina Marchetti and Giada Bernabini and Giovanni Grazi and Riccardo Giust and Alberto Rosati and Massimiliano Migliori and Antonio Pasquariello and Erica Panicucci and Giuliano Barsotti and Antonio Bellasi},
  journal={Journal of nephrology},
  year={2010},
  volume={23 5},
  pages={556-62}
}
BACKGROUND Despite substantial progress in medical care, the mortality rate remains unacceptably high in dialysis patients. Evidence suggests that bone mineral dismetabolism (CKD-MBD) might contribute to this burden of death. However, to date only a few papers have investigated the clinical relevance of serum mineral derangements and the impact of different therapeutic strategies on mortality in a homogeneous cohort of south European dialysis patients. METHODS The RISCAVID study was a… CONTINUE READING